Gynecologic Cancer clinical trials at UCSF
3 research studies open to eligible people
Gynecologic cancer is cancer that starts in a person’s reproductive organs. UCSF is testing a hybrid pilot program that combines online tools with personalized movement plans to assess feasibility. UCSF is measuring molecular markers during treatment to understand cancer-related fatigue.
Exercise and Movement to Enhance Resiliency in Cancer Patients
open to eligible females ages 18 years and up
This is a single-center, pilot, hybrid type 1 design implementation study to evaluate the feasibility and implementation of a personalized digital exercise program and a virtual support group to improve patient-centered outcomes in patients receiving treatment for gynecologic cancer receiving treatment at University of California, San Francisco.
San Francisco, California
Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT
open to eligible people ages 18 years and up
Cancer-related fatigue (CRF) is a significant problem for cancer patients. This prospective, basic science, observational study will evaluate for changes in CRF associated with molecular characteristics prior to, during, and at the completion of non-investigational, standard-of-care, combined chemotherapy and radiation therapy (CCRT) and to develop and assess predictive models for CRF severity.
San Francisco, California
PROmOting Gynecologic Cancer Patients With Frailty to Achieve Functional Recovery
open to eligible females ages 18 years and up
This study seeks to understand how frailty, a term that describes people who are more vulnerable stressors such as a new medical problem, affects the outcomes and quality of life in adult patients with gynecologic cancer.
San Francisco, California and other locations
Our lead scientists for Gynecologic Cancer research studies include Sue Yom, MD Stephanie Cham, MD.
Last updated: